期刊文献+

类法尼醇X受体在巨噬细胞中下调单核细胞趋化蛋白1的表达 被引量:1

Downregulation of Monocyte Chemoattractant Protein-1 by Farnesoid X Receptor in Murine Macrophages
下载PDF
导出
摘要 目的研究小鼠巨噬细胞株ANA-1中类法尼醇X受体的表达情况,并进一步研究类法尼醇X受体天然配体鹅脱氧胆酸在ANA-1中对单核细胞趋化蛋白1表达的影响,以探讨类法尼醇X受体在动脉粥样硬化发生发展中的作用。方法应用逆转录聚合酶链反应检测类法尼醇X受体在ANA-1细胞中的表达,及鹅脱氧胆酸处理后单核细胞趋化蛋白1的转录水平,Westernblot检测类法尼醇X受体的表达及其激活后对自身蛋白表达的调节,以及单核细胞趋化蛋白1蛋白的表达水平。结果类法尼醇X受体在ANA-1中表达,并依赖鹅脱氧胆酸浓度自我上调,鹅脱氧胆酸能显著下调单核细胞趋化蛋白1的表达水平(P<0.05)。结论类法尼醇X受体在小鼠巨噬细胞株ANA-1中组成型表达并呈配体浓度依赖性自我上调,类法尼醇X受体激活后可通过直接或间接方式下调单核细胞趋化蛋白1的表达。 Aim To investigate expression of famesoid X receptor (FXR) in murine macrophage cell line ANA-1 and evaluate the effect of FXR agonist ehenodexyeholie acid (CI)CA) on the expression of monocyte ehemoattractant protein- 1 (MCP- 1 ) in ANA-1 cells. Methods ANA-1 cells were cultured and treated with FXR agonist CI)CA. The mRNA level of FXR and MCP-1 were detected by reverse transcription-polymerase chain reaction (RT-PCR). Western blot was used to assess the expression of FXR and MCP-1 protein level. Results FXR expressed in ANA-1 cells and acted in an autoregulatory fashion, CD- CA significantly reduced MCP- 1 mRNA and protein level in ANA-1 cells ( P 〈 0.05). Conclusions FXR experss in murine macrophage cell line ANA-1. After activated by CDCA, FXR may downregulate MCP-1 directly or indirectly.
出处 《中国动脉硬化杂志》 CAS CSCD 2008年第1期21-24,共4页 Chinese Journal of Arteriosclerosis
基金 第三军医大学留学回国人员启动基金(06HG010) 重庆市自然科学基金(CSTC 2007BB5050)
关键词 分子生物学 类法尼醇x受体 核受体 胆汁酸 单核细胞趋化蛋白1 ANA-1细胞株 动脉粥样硬化 Farnesoid X Receptor Nuclear Receptor Chenodexycholic Acid Monocyte Chemoattractant Protein-1 Macrophage Atherosderosis
  • 相关文献

参考文献20

  • 1Luo Y, Laning J, Hayashi M, et al. Serologic analysis of the mouse beta chemokine JE/monocyte chemoattractant protein-1[J]. J Immunol, 1994,153(8):3708-716.
  • 2Seon Il Jang, Young-Jun Kim, Hyoung Jin Kim, et al. Scoparone inhibits PMA-induced IL-8 and MCP-1 production through suppression of NF-κB activation in U937 cells[J]. Life Sci, 2006,79:2937-943.
  • 3李爱民,何作云,周小波,覃军,耿建萌.氯沙坦对血管平滑肌细胞内单核细胞趋化因子-1表达的影响[J].中国动脉硬化杂志,2001,9(2):108-111. 被引量:8
  • 4Ping DS, Gunther Bonekhoudt, Zhang FP, et al. Sp1 binding is critical for promoter assembly and activation of the MCP-1 gene by tumor necrosis factor[J]. J Biol Chem, 2000,275(3):1708-714.
  • 5Chih-Hao Lee, Ajay Chawla, Ned urbiztondo, et al. Transcriptional repression of atherogenic inflammation: modulation by PPARγ[J]. Science, 2003,302(17):453-457.
  • 6Joseph SB, Castrillo A, Laffitte BA, et al. Reciprocal regulation of inflammation and lipid metabolism by liver X receptors[J]. Nat Med, 2003,9(2):213-219.
  • 7Makishima M, Okamoto AY, Repa JJ, et al. Identification of a nuclear receptor for bile acids[J]. Science, 1999,284:1352-365.
  • 8Zhang Y, Kast-Wolbern HR, Edwards PA. Natural structural variants of the nuclear receptor farnesoid X receptor affect transcriptional activation[J]. J Biol Chem, 2003,278(1):1104-011.
  • 9Lew JL, ZHao A, Yu J, et al. The farnesoid X receptor controls gene expression in a ligand-and promoter-selective fashion[J]. J Biol Chem, 2004,279:8856-861.
  • 10He FT,Li J, Mu Y, et al. Downregulation of endothelin-1 by farnesoid X receptor in vascular endothelial cells[J]. Circ Res, 2006,98:192-199.

二级参考文献7

  • 1Duff JL,Berk BC,Corson MA.Angiotensin Ⅱ stimulates the pp44 and pp42 mitogen-activated protein kinases in cultured aortic smooth muscle cells[].Biochemical and Biophysical Research Communications.1992
  • 2Hernandez-Presa M,Butos C,Ortego M,et al.Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-κB activation,monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis[].Circulation.1997
  • 3Kohno M,Yokokawa K,Kano H,et al.Adrenomedullin is a potent inhibitor of angiotensin Ⅱ induced migration of human coronary artery smooth muscle cells[].Journal of Hypertension.1997
  • 4Ruiz OM,Lorenzo O,Ruperez M,et al.Angiotensin Ⅱ activated nuclear transcription factor-κB through AT1 and AT2 in smooth muscle cells: molecular mechanisms[].Circulation Research.2000
  • 5Suzuki YJ,Mizuno M,Packer L,et al.Signal transduction for nuclear factor-κB activation: proposed location of antioxidant-inhibital step[].J Immunol.1994
  • 6Lorell BH.Roles of angiotensin AT1 and AT2 receptors in cardiac hypertrophy and disease[].The American Journal of Cardiology.1999
  • 7Nelken NA,Coughlin SR,Gordon D,et al.Monocyte chemoattractant protein-1 in human athermatous plaques[].The Journal of Clinical Investigation.1991

共引文献7

同被引文献8

  • 1Kumar S N, Boss J M. Site A of the MCP-1 distal regulatory region functions as a transcriptional modulator through the transcription factor NF1[J]. Mol Immunol, 2000, 37(11): 623 -632.
  • 2Ahmed R A, Murao K, lmachi H, et al. c-Jun N-terminal kinases inhibitor suppresses the TNF-alpha induced MCP-1 expression in human umbilical vein endothelial cells[J]. Endocrine, 2009, 35(2): 184-188.
  • 3Mukerjee R, Deshmane S L, Darbinian N, et al. St. John' s Wort protein, p27SJ, regulates the MCP-1 promoter[J]. Mol Immunol, 2008, 45 ( 15 ) : 4028 - 4035.
  • 4Ping D, Boekhoudt G, Zhang F, et al. Spl binding is critical for promoter assembly and aetivation of the MCP-1 gene by tumor necrosis factor[J]. J Biol Chem, 2000, 275(3) : 1708 -1714.
  • 5Claudel T, Sturm E, Duez H, et al. Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response element[J]. J Clin Invest, 2002, 109(7) : 961 -971.
  • 6Das A, Femandez-Zapico M E, Cao S, et al. Disruption of an SP2/KLF6 repression complex by SlIP is required for farnesoid X receptor-induced endothelial cell migration[J]. J Biol Chem, 2006, 281 (51): 39105 -39113.
  • 7He F, Li J, Mu Y, et al. Downregulation of endothelin-1 by famesoid X receptor in vascular endothelial cells[J]. Cire Res, 2006, 98(2) : 192 - 199.
  • 8Kim M S, Shigenaga J, Moser A, et al. Repression of farnesoid X receptor during the acute phase response[J]. J Biol Chem, 2003, 278 (11): 8988-8995.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部